Revenue
$915.9m
-6.1% ↓ vs $975.7m
FY24 met the $43m EBITDA guide but H2 NPAT turned negative and the cash rebound was driven by a $17.4m working-capital release.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY24 vs FY23
Revenue
$915.9m
-6.1% ↓ vs $975.7m
EBITDA
$44.2m
-27.8% ↓ vs $61.2m
Net profit after tax
$3.1m
-82.3% ↓ vs $17.5m
Net cash inflow from operating activities
$57.7m
+126.3% ↑ vs $25.5m
Declared dividend per share
—
— vs 10.0c
Operating profit
$15.4m
-54.2% ↓ vs $33.5m
Profit before tax
$5.3m
-77.8% ↓ vs $23.9m
Cash and cash equivalents
$3.8m
-18.5% ↓ vs $4.6m
What changed
Operating EBITDA fell 27.8% to $44.2m, in line with the company's revised guidance of around $43m. The board declared no final dividend for FY24, against a 10 cent prior-year final.
Net cash inflow from operating activities moved the other way, rising 126.3% to $57.7m, with the second-half implied OCF of $118.6m more than reversing the $60.9m HY24 outflow. Capex stepped up 33.0% to $22.8m. Gross borrowings reduced to $63.0m from $70.0m, but net debt to EBITDA rose to 1.34x from 1.07x as the EBITDA decline outweighed the debt reduction.
What matters
Operating profit fell 54.2% to $15.4m and PBT fell 77.8%, so the drop-through from a 6.1% revenue decline was severe. The effective tax rate widened to 42.5% from 26.8%, which means PBT is the cleaner operating read at -77.8%; the headline NPAT decline of 82.3% overstates the operating slip by roughly 4.5 percentage points.
The cash-flow rebound is balance-sheet-assisted, not earnings-driven. Working capital fell $17.4m as inventories declined $12.3m (-11.5%) and trade debtors fell $8.2m (-7.0%). Free cash flow before leases of $34.9m sits at n/m of NPAT, a ratio that flags the gap between the cash optics and the underlying earnings result rather than confirming a durable cash quality improvement.
The dividend cancellation reframes the leverage signal. With $57.7m of OCF in hand, the choice not to pay any final dividend (against a 43.1% prior-year payout ratio on NPAT) suggests management is prioritising debt and balance-sheet capacity over distribution, consistent with leverage drifting up on a net-debt-to-EBITDA basis. ROE fell to 1.9% from 10.4%.
Expectations
That removes one source of disappointment, but the shape of the year is unhelpful: HY24 NPAT was $9.9m and full-year NPAT is $3.1m, implying a second-half NPAT of approximately -$6.9m. The deterioration accelerated into H2 as sheep-meat farmgate weakness, elevated rates and on-farm cost pressures bit harder.
No FY25 guidance is supplied in this release. The release commentary cites weak China sheep-meat demand, elevated interest rates and clients deferring spend and reducing debt, which means the H2 run-rate, not the full-year average, is the more relevant base for thinking about FY25.
Quality of result
OCF/EBITDA jumped to 130.7% from 41.7%, but the swing is largely accounted for by the $17.4m reduction in operating working capital and the H1-to-H2 reversal of the seasonal cash cycle. Receivable days (43.6) and inventory days (37.9) are both modestly below prior year, so the working capital release looks at least partly volume- and demand-driven rather than collections-driven, which limits the read-through to FY25 cash flow.
Earnings quality weakened on multiple axes. Both reportable segments contributed: Retail & Water result fell to $41.0m from $54.1m, and Agency result fell to $12.3m from $16.1m, with shares of group revenue largely unchanged. Capex intensity rose to 2.5% of revenue from 1.8%, so the FCF figure also benefits from a higher denominator on the cash side without any matching uplift in earnings power. The cleaner read is that the underlying business produced materially less profit on slightly less revenue, and the cash result borrowed from balance-sheet contraction.
Unresolved
This briefing cannot assess the durability of FY25 trading conditions, the trajectory of farmgate prices, or the timing of any dividend reinstatement.
Chat
Ask follow-up questions about PGG Wrightson's FY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
NZX Template Results Announcement 30 June 2024
FY24 / results announcementPGW Financial Statements_30 June 2024
FY24 / financial reportPGW Results Announcement 30 June 2024
FY24 / results releasePGW Financial Statements for Year Ended 30 June 2023
FY23 / financial reportPGW Results Announcement FY23
FY23 / results announcementPGW Results Announcement FY23
FY23 / results releasePGW Half Year Results Announcement Details
HY24 / financial reportPGW Guidance Update
FY24 / commentaryPGW HY Results Presentation Deck_31 December 2023
FY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 4.5pp, with a distortion flag in the result.
Cash conversion quality
This result converted 130.7% of EBITDA to operating cash flow, +89.0pp versus the prior comparable period.
Leverage and balance-sheet risk
Net debt / EBITDA is 1.34x, +0.27x versus the prior comparable period.
ROE and capital efficiency
ROE was 1.9%, -8.5pp versus the prior comparable period.
Get the next PGG Wrightson briefing and related NZX reporting-season updates by email.